- Todays Market
- Indian Stock Market News March 9, 2020
DIVIS LABORATORIES at All Time High; BSE HEALTHCARE Index Down 1.5%
March 9, 2020 09:47 AM
DIVIS LABORATORIES share price has hit an all-time high at Rs 2,258 (down 0.7%).
Meanwhile, the BSE HEALTHCARE Index is at 13,891 (down 1.5%).
Among the top gainers in the BSE HEALTHCARE Index today are DIVIS LABORATORIES (down 0.2%) and SUN PHARMA (up 0.2%).
J.B.CHEMICALS (down 0.1%) and STRIDES PHARMA SCIENCE (down 0.2%) are among the top losers today.
Over the last one year, DIVIS LABORATORIES has moved up from Rs 1,704 to Rs 2,258, registering a gain of Rs 554 (up 30.5%).
The BSE HEALTHCARE has moved down from 14,131 to 13,891, loss of 240 points (down 2.7%) during the last 12 months.
The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 110.1%), J.B.CHEMICALS (up 74.3%) and IPCA LABS (up 61.5%).
What About the Benchmark Indices?
The BSE Sensex is at 36,950 (down 3.6%). The top gainers among the BSE Sensex stocks today are ASIAN PAINTS (up 0.2%) and SUN PHARMA (up 0.2%). The most traded stocks in the BSE Sensex are SUN PHARMA and ASIAN PAINTS.
In the meantime, NSE Nifty is at 10,752 (down 3.5%). The top gainers in the NSE Nifty include YES BANK (up 14.9%), BPCL (up 5.3%) and IOC (up 2.1%). Other gainers include SUN PHARMA (up 0.3%) and ASIAN PAINTS (up 0.2%).
Over the last 12 months, the BSE Sensex has moved up from 36,636 to 36,950, registering a gain of 314 points (up -1.2%).
DIVIS LABORATORIES Financial Update...
DIVIS LABORATORIES net profit down at Rs 4 billion for the quarter ended December 2019, compared to a loss of Rs 4 billion a year ago. Net Sales rose 3.5% to Rs 13.9 billion during the period as against Rs 13.4 billion in October-December 2018.
For the year ended March 2019, DIVIS LABORATORIES reported 54.2% increase in net profit to Rs 13.5 billion compared to net profit of Rs 8.8 billion during FY18.
Revenue of the company grew 26.4% to Rs 49 billion during FY19.
The current Price to earnings ratio of DIVIS LABORATORIES, based on rolling 12 month earnings, stands at 46.3x.